Enhanced Pharmacodynamics

Enhanced Pharmacodynamics (ePD) is a specialized clinical pharmacology and pharmacometrics consulting firm that provides strategic and technical expertise to the global pharmaceutical and biotechnology sectors. The company focuses on pharmacokinetics (PK) and pharmacodynamics (PD) modeling and simulation to streamline drug development and support regulatory filings. Their services include population PK/PD modeling, exposure-response analysis, and clinical trial simulation across various therapeutic areas. In May 2022, ePD was acquired by Certara, integrating its high-end consultancy services into Certara's broader biosimulation and model-informed drug development (MIDD) portfolio. The firm is recognized for its ability to translate complex data into actionable insights for dose optimization and risk mitigation.